コンテンツへスキップ
Merck
  • Possible nitric oxide modulation in the protective effects of rutin against experimental head trauma-induced cognitive deficits: behavioral, biochemical, and molecular correlates.

Possible nitric oxide modulation in the protective effects of rutin against experimental head trauma-induced cognitive deficits: behavioral, biochemical, and molecular correlates.

The Journal of surgical research (2014-02-04)
Anil Kumar, Puneet Rinwa, Hitesh Dhar
要旨

Traumatic head injury is turning out to be a major cause of disability and death. Nitric oxide (NO), an intercellular messenger plays a crucial role in the pathophysiology of several neurologic disorders. Therefore, the present study was designed to investigate the effects of rutin, a well-known flavonoid against cognitive deficits and neuroinflammation associated with traumatic head injury and the probable role of NO pathway in this effect. Wistar rats were exposed to head trauma using weight drop method and kept for a postsurgical rehabilitation period of 2 wk. Later, animals were administered with rutin (20, 40, and 80 mg/kg; per oral) alone and in combination with NO modulators such as N(G)-nitro-L-arginine methyl ester and L-arginine, daily for another 2 wk. Head injury caused impaired spatial navigation in Morris water maze test and poor retention in elevated plus maze task. Furthermore, there was a significant rise in acetylcholinesterase activity, oxidative stress, neuroinflammation (tumor necrosis factor α), and neuronal apoptosis (caspase-3) in both cortex and hippocampal regions of traumatized rat brain. Rutin significantly attenuated these behavioral, biochemical, and molecular alterations associated with head trauma. Furthermore, pretreatment of N(G)-nitro-L-arginine methyl ester (10 mg/kg, intraperitoneally), a nonspecific nitric oxide synthase inhibitor, with subeffective dose of rutin (40 mg/kg) potentiated the protective effects; however, pretreatment of L-arginine (100 mg/kg; intraperitoneally), an NO donor, reversed the effects of rutin. The present study suggests that NO modulation could possibly be involved in the neuroprotective effects of rutin against head trauma-induced cognitive deficits, neuroinflammation, and apoptotic signaling cascade.

材料
製品番号
ブランド
製品内容

Sigma-Aldrich
カタラーゼ ウシ肝臓由来, lyophilized powder, 2,000-5,000 units/mg protein
Sigma-Aldrich
L-アルギニン, from non-animal source, meets EP, USP testing specifications, suitable for cell culture, 98.5-101.0%
Sigma-Aldrich
L-アルギニン, reagent grade, ≥98%
Sigma-Aldrich
Nω-ニトロ-L-アルギニンメチルエステル 塩酸塩, ≥97% (TLC), powder
Sigma-Aldrich
アセチルコリンエステラーゼ Electrophorus electricus(電気ウナギ)由来, Type VI-S, lyophilized powder, 200-1,000 units/mg protein
Sigma-Aldrich
カタラーゼ ウシ肝臓由来, lyophilized powder, ≥10,000 units/mg protein
Sigma-Aldrich
カタラーゼ ウシ肝臓由来, powder, suitable for cell culture, 2,000-5,000 units/mg protein
Sigma-Aldrich
L-アルギニン, BioUltra, ≥99.5% (NT)
Sigma-Aldrich
カタラーゼ ウシ肝臓由来, aqueous suspension, 40,000-60,000 units/mg protein (E1%/405)
Sigma-Aldrich
L-アルギニン, 99%, FCC, FG
Sigma-Aldrich
カタラーゼ ウシ肝臓由来, aqueous suspension, 10,000-40,000 units/mg protein
SAFC
L-アルギニン
Sigma-Aldrich
アセチルコリンエステラーゼ Electrophorus electricus(電気ウナギ)由来, Type V-S, lyophilized powder, ≥1,000 units/mg protein
Sigma-Aldrich
アセチルコリンエステラーゼ ヒト, recombinant, expressed in HEK 293 cells, lyophilized powder, ≥1,000 units/mg protein (BCA)
Sigma-Aldrich
カタラーゼ ウシ肝臓由来, aqueous solution, ≥30,000 units/mg protein
Supelco
L-アルギニン, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
アセチルコリンエステラーゼ ヒト赤血球由来, buffered aqueous solution, ≥500 units/mg protein (BCA)
Sigma-Aldrich
カタラーゼ from Aspergillus niger, ammonium sulfate suspension, ≥4,000 units/mg protein
アルギニン, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
カタラーゼ ウシ肝臓由来, ≥20000 units/mg protein, lyophilized powder
Sigma-Aldrich
カタラーゼ ヒト赤血球由来, ≥90% (SDS-PAGE), buffered aqueous solution, ≥30,000 units/mg protein